ERBB2 and breast cancer: In this cohort study of 239 211 women with breast cancer, the incidence of HR-negative and ERBB2 (formerly HER2)–positive, HR-positive and ERBB2-positive, and triple-negative breast cancer was higher in Black women compared with non-Hispanic White women.